A detailed history of Sea Otter Advisors LLC transactions in Prometheus Biosciences, Inc. stock. As of the latest transaction made, Sea Otter Advisors LLC holds 3,000 shares of RXDX stock, worth $0. This represents 0.26% of its overall portfolio holdings.

Number of Shares
3,000
Holding current value
$0
% of portfolio
0.26%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding RXDX

About Prometheus Biosciences, Inc.


  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Sea Otter Advisors LLC Portfolio

Follow Sea Otter Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Otter Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Otter Advisors LLC with notifications on news.